2024
DOI: 10.1007/s11906-024-01293-5
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review

James P. Sheppard,
Athanase Benetos,
Jonathan Bogaerts
et al.

Abstract: Purpose of Review To summarise the evidence regarding which patients might benefit from deprescribing antihypertensive medications. Recent Findings Older patients with frailty, multi-morbidity and subsequent polypharmacy are at higher risk of adverse events from antihypertensive treatment, and therefore may benefit from antihypertensive deprescribing. It is possible to examine an individual’s risk of these adverse events, and use this to identify those peo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 53 publications
0
4
0
Order By: Relevance
“…While the short-term evidence is supportive, there is uncertainty regarding the longer-term benefits and harms. 20 …”
Section: Evidence For Deprescribing Antihypertensive Drugsmentioning
confidence: 99%
See 3 more Smart Citations
“…While the short-term evidence is supportive, there is uncertainty regarding the longer-term benefits and harms. 20 …”
Section: Evidence For Deprescribing Antihypertensive Drugsmentioning
confidence: 99%
“…The risk of adverse outcomes when deprescribing, such as withdrawal effects, can be minimised or prevented through appropriate patient engagement, planning, tapering, monitoring and clinical handover. 17 , 18 , 20 , 29 , 30 If there are other prescribers involved in the patient’s care (e.g. a cardiologist), they should also be engaged in deprescribing decisions.…”
Section: How To Deprescribementioning
confidence: 99%
See 2 more Smart Citations